Serum intact fibroblast growth factor 23 in healthy paediatric population

It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent. We present the results of the cross-sectional study concerning FGF23 levels in healthy Polish children.

Guardado en:

Detalles Bibliográficos
Autores principales:	Stanczyk Malgorzata, Chrul Slawomir, Wyka Krystyna, Tkaczyk Marcin
Formato:	article
Lenguaje:	EN
Publicado:	De Gruyter 2021
Materias:	child fibroblast growth factors renal insufficiency Medicine R
Acceso en línea:	https://doaj.org/article/477ff00ad189485c8eae4f3d91cf778b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:477ff00ad189485c8eae4f3d91cf778b
record_format	dspace
spelling	oai:doaj.org-article:477ff00ad189485c8eae4f3d91cf778b2021-12-05T14:10:54ZSerum intact fibroblast growth factor 23 in healthy paediatric population2391-546310.1515/med-2021-0288https://doaj.org/article/477ff00ad189485c8eae4f3d91cf778b2021-07-01T00:00:00Zhttps://doi.org/10.1515/med-2021-0288https://doaj.org/toc/2391-5463It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent. We present the results of the cross-sectional study concerning FGF23 levels in healthy Polish children.Stanczyk MalgorzataChrul SlawomirWyka KrystynaTkaczyk MarcinDe Gruyterarticlechildfibroblast growth factorsrenal insufficiencyMedicineRENOpen Medicine, Vol 16, Iss 1, Pp 1022-1027 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	child fibroblast growth factors renal insufficiency Medicine R
spellingShingle	child fibroblast growth factors renal insufficiency Medicine R Stanczyk Malgorzata Chrul Slawomir Wyka Krystyna Tkaczyk Marcin Serum intact fibroblast growth factor 23 in healthy paediatric population
description	It is believed that fibroblast growth factor 23 (FGF23) can become an early biomarker of chronic kidney disease progression. Data on FGF23 age dependency are inconsistent. We present the results of the cross-sectional study concerning FGF23 levels in healthy Polish children.
format	article
author	Stanczyk Malgorzata Chrul Slawomir Wyka Krystyna Tkaczyk Marcin
author_facet	Stanczyk Malgorzata Chrul Slawomir Wyka Krystyna Tkaczyk Marcin
author_sort	Stanczyk Malgorzata
title	Serum intact fibroblast growth factor 23 in healthy paediatric population
title_short	Serum intact fibroblast growth factor 23 in healthy paediatric population
title_full	Serum intact fibroblast growth factor 23 in healthy paediatric population
title_fullStr	Serum intact fibroblast growth factor 23 in healthy paediatric population
title_full_unstemmed	Serum intact fibroblast growth factor 23 in healthy paediatric population
title_sort	serum intact fibroblast growth factor 23 in healthy paediatric population
publisher	De Gruyter
publishDate	2021
url	https://doaj.org/article/477ff00ad189485c8eae4f3d91cf778b
work_keys_str_mv	AT stanczykmalgorzata serumintactfibroblastgrowthfactor23inhealthypaediatricpopulation AT chrulslawomir serumintactfibroblastgrowthfactor23inhealthypaediatricpopulation AT wykakrystyna serumintactfibroblastgrowthfactor23inhealthypaediatricpopulation AT tkaczykmarcin serumintactfibroblastgrowthfactor23inhealthypaediatricpopulation
_version_	1718371600351363072

Serum intact fibroblast growth factor 23 in healthy paediatric population

Ejemplares similares